Opioid diarylmethylpiperazines and piperdines
US5658908A · kind A · utility
42Cited by
4References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 3, 1994 |
| Grant date | Aug 19, 1997 |
| Priority date | — |
| Expiry date | Aug 3, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/06078
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Diarylmethylpiperazine compounds having utility as receptor-binding species, e.g., for mediating analgesia, and for combatting drug addiction, alcohol addiction, and drug overdose. The compounds may be administered orally, rectally, topically, nasally, ophthalmically, or parenterally (subcutaneously, intramuscularly, and intravenously), for veterinary and human use, and include delta receptor and mu receptor binding species.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.